Open access
Clinical Outcomes, Treatment Patterns, and Molecular Heterogeneity of TFE3‐Rearranged Renal Cell Carcinoma: A Multicenter Real‐World Study
Shu-Xuan Zhu
Si-Qi Zhou
Xi Tian
Jun Wang
Ze Wang
Jun Jiang
Qiu-Li Liu
Xin Gou
Xiang-Le Zhou
Jun Gu
Jian-Feng Yang
Jian-Hui Chen
Shu-shang Chen
Wen-Feng Wang
Aihetaimujiang Anwaier
Kun Chang
Yuan-Yuan Qu
J. Brugarolas
Wen-Hao Xu
Hai-Liang Zhang
Ding-Wei Ye
Medicine
Abstract
TFE3‐rearranged renal cell carcinoma (TFE3‐rRCC) is uncommon and encompasses biologically diverse tumors, while evidence to guide systemic treatment remains sparse. We examined clinical outcomes, treatment patterns, and molecular features in a multicenter real‐world cohort.